CNS Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.

About CNSP

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. 

CEO
John M. Climaco
CEOJohn M. Climaco
Employees
5
Employees5
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2017
Founded2017
Employees
5
Employees5

CNSP Key Statistics

Market cap
5.13M
Market cap5.13M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
190.70K
Average volume190.70K
High today
$0.9399
High today$0.9399
Low today
$0.8385
Low today$0.8385
Open price
$0.9271
Open price$0.9271
Volume
71.02K
Volume71.02K
52 Week high
$82.50
52 Week high$82.50
52 Week low
$0.7303
52 Week low$0.7303

People also own

Based on the portfolios of people who own CNSP. This list is generated using Robinhood data, and it’s not a recommendation.
Tonix Pharmaceuticals
XTI Aerospace, Inc.
Mullen Automotive
SNDL
Plug Power
Tilray Brands
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.